1. Natural Phycocyanin/Paclitaxel Micelle Delivery of Therapeutic P53 to Activate Apoptosis for HER2 or ER Positive Breast Cancer Therapy.
- Author
-
Zhang LK, Li Y, Zhai L, Tang Y, Jiao Y, Mei Y, Yang R, You R, Yin L, Ni H, Ge J, and Guan YQ
- Subjects
- Female, Humans, Animals, Cell Line, Tumor, Receptors, Estrogen metabolism, Mice, Mice, Inbred BALB C, Antineoplastic Agents pharmacology, Antineoplastic Agents therapeutic use, Mice, Nude, Micelles, Tumor Suppressor Protein p53 metabolism, Tumor Suppressor Protein p53 genetics, Breast Neoplasms drug therapy, Breast Neoplasms pathology, Paclitaxel pharmacology, Paclitaxel therapeutic use, Phycocyanin pharmacology, Phycocyanin therapeutic use, Phycocyanin chemistry, Apoptosis drug effects, Receptor, ErbB-2 metabolism
- Abstract
The P53 gene is commonly mutated in breast cancer, protein based the gene as anticancer drugs could provide efficient and stable advantages by restoring the function of the wild-type P53 protein. In this study, we describe the creation and utilization of a micelle composed by natural phycocyanin and paclitaxel and grafting anti-HER2 (PPH), which effectively packages and transports recombinant P53 protein with anti-ER (PE), resulting in a new entity designated as PE@PPH, to address localization obstacles and modify cellular tropism to the cell membrane or nucleus. The results indicate that PE@PPH has strong antitumor properties, even at low doses of PTX both in vitro and in vivo . These findings suggest that PE@PPH could be an enhancing micelle for delivering therapeutic proteins and promoting protein functional recovery, particularly in addressing the challenges posed by tumor heterogeneity in breast cancer.
- Published
- 2024
- Full Text
- View/download PDF